MADISON, Wis. – Propeller Health plans to use $21.5 million in recent funding to modernize the management of respiratory diseases like COPD and asthma. “We aim to make today’s treatments more accessible, personal, powerful and convenient for each person who uses them, and enable physicians to measure, analyze and act to help their patients,” said David Van Sickle, Propeller CEO. Propeller uses sensors that attach to inhalers, then sync to a companion app. The platform is able to integrate with connected medications and other sources, and can develop personalized therapy plan for users.
You are here: / / Propeller Health looks to expand respiratory therapy platform